PEDIATRIC VACCINE STOCKPILES A Status Report on the Pediatric Vaccine Stockpiles November 2005 Gregory S. Wallace, M.D., M.S., M.P.H. Chief, Program Support.

Slides:

Advertisements

Similar presentations

Characterization of Vaccine Waste Resulting from Storage Failures Identified by Immunization Programs, July 13 through September 4, 2009 Kelly L. Moore,

Advertisements

Supply of OPV for Pulse Polio Immunization Programme Twenty Third Meeting Of the India Expert Advisory Group (IEAG) for Polio Eradication on July.

ACIP Meeting Update November 4 th

To protect the health and environment of all Kansans by promoting responsible choices. Immunization Program 2009 H1N1 Adventure Governor’s Child Health.

Registry Support of Immunization Program Activities Lance Rodewald, M.D. Director Immunization Services Division, NIP/CDC Bill Brand, M.P.H. Vice-President,

Recommendations on IAP Immunization Time Table for 2012 Vipin M. Vashishtha, MD, FIAP Convener, IAPCOI December 24 th, 25.

What's New on the Child and Adolescent Immunization Schedules William L. Atkinson, MD, MPH National Center for Immunization and Respiratory Diseases William.

Getting the shots! Let’s get all kids immunized Lawrence J. Losey, MD, FAAP Brunswick Pediatrics, CMMG.

National Immunization Program Report NVAC Washington, DC  February 3-4, 2004 Stephen L. Cochi, M.D., M.P.H. Acting Director, National Immunization Program.

VTrckS What is the Vaccines for Children (VFC) Program?

Public Health Service Response to Influenza Vaccine Supply Problems Lance E. Rodewald, MD Immunization Services Division National Immunization Program.

Economic Evaluation of Routine Childhood Immunization with DTaP, Hib, IPV, MMR and HepB Vaccines in the United States, 2001 Fangjun Zhou Health Services.

THE NATIONAL INFLUENZA VACCINE SUMMIT: UPDATE Raymond A. Strikas, M.D. Immunization Services Division National Immunization Program Coordinating Center.

Vaccines for Children Program Stockpile Status National Vaccine Advisory Committee February 4, 2010 Washington, DC Lance E Rodewald, MD Director, Immunization.

NVAC Vaccine Finance Working Group Update Gus Birkhead, MD, MPH Chair, NVAC Vaccine Working Group September 26, 2006.

IOM Report on Financing Vaccines in the 21 st Century: National Vaccine Advisory Committee Follow-up Alan R. Hinman, MD, MPH Chair, NVAC Workgroup on IOM.

Implementing New Vaccines and Vaccine Recommendations National Vaccine Advisory Committee Washington, DC September 26, 2006 Lance E. Rodewald, MD Director,

Food and Drug Administration

Vaccine Supply Update Jeanne M. Santoli Vaccine Supply and Assurance Branch January 22, 2010.

Influenza Vaccine Supply : Issues and Opportunities Raymond A. Strikas, M.D. National Immunization Program Coordinating Center for Infectious Diseases.

Preview of the Influenza Season: Programmatic Challenges and Opportunities Jeanne M. Santoli, MD, MPH National Immunization Program.

Childhood Vaccine Financing: Implications for States National Vaccine Advisory Committee November 29, 2005 Washington, DC Lance E. Rodewald, MD Director,

Influenza Vaccination Update for Jeanne M. Santoli, MD, MPH Deputy Director, Immunization Services Division National Center for Immunization and.

Expanded Influenza Vaccination Recommendations: Developing an Implementation Strategy Litjen (L.J) Tan, MS, PhD American Medical Association Co-Chair,

State Health Agency Perspectives on the Implementation of New Vaccines Presentation to the National Vaccine Advisory Committee September 26, 2006 Calvin.

2005 National Immunization Survey Stephen L. Cochi, M.D., M.P.H. Acting Director National Immunization Program, CDC National Press Club July 27, 2005 Department.

TM OPV Stockpiling in the United States Trudy V. Murphy, M.D. National Immunization Program Centers for Disease Control and Prevention February 5, 2003.

Planning for the Influenza Season: Will it be Rain, Shine, or Hurricane? National Vaccine Advisory Committee June 7, 2005 Washington, DC Raymond.

2005 AHIP Immunization Assessment Summary National Vaccine Advisory Committee November 29-30, 2005 Steve Black, MD, AHIP Liaison to NVAC Bob Rehm, Director.

National Vaccine Advisory Committee Report from the Chair Gus Birkhead, MD, MPH NVAC Chair February 3, 2010.

A Vaccine Supply Update For The U.S. Market A Presentation At The National Vaccine Advisory Committee Meeting June 3, 2003 Dean Mason Chief, Program Support.

National Vaccine Advisory Committee A Status Report on the Pediatric Vaccine Stockpiles Pediatric Vaccine Stockpiles February 8, 2005 Eddie Wilder Project.

Getting The Job Done Safe Vaccine Storage and Handling in a busy pediatric practice Speaker: Barbara Turner, RN, BSN Vaccine Manager North Fulton Pediatrics,

A Vaccine Supply Update For The U.S. Market A Presentation At National Advisory Committee Meeting February 4, 2003 Dean Mason Chief, Program Support Branch.

OVERVIEW OF THE NATIONAL INFLUENZA VACCINE SUMMIT Dennis J. O’Mara Associate Director for Adult Immunization Immunization Services Division National Immunization.

VFC Pediatric Vaccine Stockpile National Vaccine Advisory Committee October 23, 2007 Gregory S. Wallace, M.D., M.S., M.P.H. Chief, Vaccine Supply and Assurance.

Planning for the Influenza Season National Vaccine Advisory Committee February 8, 2005 Washington, DC Lance E. Rodewald, MD Director, Immunization.

Rotavirus vaccination: Issues & IAPCOI perspectives Vipin M. Vashishtha, MD, FIAP Convener, IAPCOI August 24 th & 25 th 2012.

Highlights of Recent Results from the New Health Insurance Modules of the National Immunization Survey National Vaccine Advisory Committee October 22,

Update from the Office of Vaccines Research and Review, CBER/FDA NVAC Meeting Washington, D.C. February 4-5, 2003.

CDC VACCINE STOCKPILE FISCAL AND MANAGEMENT ISSUES A Presentation At The National Vaccine Advisory Committee Meeting February 4, 2003 Kimberly S. Lane.

National Immunization Program (NIP)/Advisory Committee on Immunization Practices (ACIP) Report Stephen L. Cochi, MD, MPH Acting Director, National Immunization.

Bee Wise Immunize Governor’s Child Health Advisory Committee Immunization Workgroup Topeka, KS November 19, 2010 Sue Bowden, RN, BS Director, KDHE Immunization.

Influenza Vaccine Supply and Distribution: An Overview of the Season Jeanne M. Santoli, MD, MPH National Immunization Program.

39 th NIC, Washington DC, 21 March Daniel A. Allwine, M.S. This work is supported by Contract No from the.

Pneumococcal Vaccine Use Around the World: Successes and Challenges Adam L. Cohen, MD MPH Respiratory Diseases Branch, Division of Bacterial Diseases Centers.

Carol Friedman, D.O. Associate Director for Adult Immunization Immunization Services Division National Center for Immunization and Respiratory Diseases.

SNIC, NIC Connecting the Connectors: Bringing Together Business Coalitions, Employers, Health Plans, Pediatricians and Public Health Pam Beal Southern.

Evaluation of the 2004 pneumococcal conjugate vaccine shortage utilizing data from the Michigan Childhood Immunization Registry Norma Allred, PhD, John.

2007 National Health Policy Conference Preparing to Protect: Flu Vaccines from Production to Consumption A Public Health Perspective Daniel Hopfensperger.

What’s Up With All Those Other Vaccines?

Immunization Safety Branch, NIP, CDC

Georgia Immunization Rates

JON S. ABRAMSON, M.D. DEPARTMENT OF PEDIATRICS

Immunogenicity and Safety of a Combination Diphtheria, Tetanus Toxoid, Acellular Pertussis, Hepatitis B, and Inactivated Poliovirus Vaccine Coadministered.

Improving Pediatric Immunization Rates In Children Under the Age of 3 in Two University Community Clinics Chad Alan Spain, MD Kyle Bradford Jones, MD.

Emerging Gaps in Financing for New Vaccines

Are US Children In Compliance with Vaccination Recommendations?

What’s going on out there

Influenza Vaccine Distribution

Women’s Health Care and Education Coalition

Number of catch-up doses needed (n = 200) at admission and at 1-month follow-up by vaccine type among 95 children found to be underimmunized per ACIP guidelines.

Coverage Rates in Texas

DSHS Adult Vaccine Program

Update on the Nation’s Immunization

Racial and ethnic disparities in childhood immunization rates have declined as overall coverage increased. Percentage of children ages 19 to 35 months.

Healthy People 2010 Focus Area 14

National Immunization Conference

Immunization in the Era of Health Reform: What’s Next?

The Texas Child Care Immunization Assessment Survey

Presentation transcript:

PEDIATRIC VACCINE STOCKPILES A Status Report on the Pediatric Vaccine Stockpiles November 2005 Gregory S. Wallace, M.D., M.S., M.P.H. Chief, Program Support Branch (PSB) Immunization Services Division (ISD) National Immunization Program (NIP)

History 1983Began stockpiling pediatric vaccines 1983Began stockpiling pediatric vaccines 1993VFC legislation enacted; established requirement for 6-month stockpile of all routinely recommended childhood vaccines 1993VFC legislation enacted; established requirement for 6-month stockpile of all routinely recommended childhood vaccines 1993Began purchasing vaccines for stockpile 1993Began purchasing vaccines for stockpile 2002Revenue recognition issues arise 2002Revenue recognition issues arise 2005All vaccine manufacturers agree to sell vaccines to CDC for stockpile 2005All vaccine manufacturers agree to sell vaccines to CDC for stockpile

Pediatric Vaccine Stockpiles What happened? What happened? May CDC met with SEC May CDC met with SEC June-July SEC met with the corporate HQ’s of all four vaccine manufacturers June-July SEC met with the corporate HQ’s of all four vaccine manufacturers August All of the vaccine manufacturers agreed to participate in the CDC Pediatric Vaccine Stockpile Program August All of the vaccine manufacturers agreed to participate in the CDC Pediatric Vaccine Stockpile Program Regardless of the revenue recognition issues Regardless of the revenue recognition issues Based on their capacity to sell CDC vaccines for the stockpile Based on their capacity to sell CDC vaccines for the stockpile

Pediatric Vaccine Stockpiles Fiscal Year (FY) 2005 activity Fiscal Year (FY) 2005 activity All four manufacturers agreed in FY 2005 to sell vaccine to CDC for the Pediatric Vaccine Stockpiles All four manufacturers agreed in FY 2005 to sell vaccine to CDC for the Pediatric Vaccine Stockpiles $158.8M obligated to purchase 5,500 doses $158.8M obligated to purchase 5,500 doses CDC established new target quantities for stockpiled vaccine CDC established new target quantities for stockpiled vaccine CDC established revised plans for future vaccine purchases for the stockpile CDC established revised plans for future vaccine purchases for the stockpile

Pediatric Vaccine Stockpiles Current Status

Purchased/Undelivered Doses FY 2003 FY 2003 − 2.4 million doses IPV (sanofi) − 2 million doses HepB (GSK) − 1 million doses HepA (GSK) − 0.8 million doses PCV7 (Wyeth) FY 2005 FY 2005 − 0.5 million doses Hib (sanofi) − 1.5 million doses DTaP (sanofi & GSK) − 2 million doses PCV7 (Wyeth) − 0.5 million doses DTaP/HepB/IPV

Pediatric Vaccine Stockpile s Stockpile management Stockpile management Target quantities workgroup Target quantities workgroup NVAC & ACIP participation NVAC & ACIP participation Contract review and revision Contract review and revision Purchase vs. delivery price Purchase vs. delivery price Third-party distributor Third-party distributor

Next Steps Review and revise contracts with two (2) manufacturers who have existing stockpile contracts Review and revise contracts with two (2) manufacturers who have existing stockpile contracts Establish new stockpile contracts with two(2) vaccine manufacturers Establish new stockpile contracts with two(2) vaccine manufacturers Incorporate stockpile management into VMBIP Incorporate stockpile management into VMBIP